Tofacitinib for Refractory Dermatomyositis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tofacitinib as Treatment for Refractory Dermatomyositis: A Retrospective Study From Two Academic Medical Centers
J Am Acad Dermatol 2021 Jul 08;[EPub Ahead of Print], MS Min, A Alsarheed, B Kassamali, DR Mazori, M Schaefer, JF Merola, G Cobos, AH LaChance, RA VleugelsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.